MedTrace Logo

Chemotherapy Resistance and Sensitivity Testing in Lung Tumors

NCT01570855 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2016-04-27

No results posted yet for this study

Summary

The purpose of this study is to screen chemotherapy drugs currently used to treat lung cancer and determine the most effective treatment based on results of chemo sensitivity testing on the patients own cancer cells in the laboratory. The results of this screening will not influence the patients treatment.

Conditions

Sponsors & Collaborators

  • Cabell Huntington Hospital

    collaborator OTHER

  • Marshall University

    lead OTHER

Principal Investigators

  • Pier P. Claudio, M.D., Ph. D · Marshall University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-05-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01570855 on ClinicalTrials.gov